Levetiracetam in the treatment of epilepsy
Bassel Abou-KhalilDepartment of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USAAbstract: Epilepsy is a common chronic disorder that requires long-term antiepileptic drug therapy. Approximately one half of patients fail the initial antiepileptic drug and about 35% are refra...
Guardado en:
Autor principal: | Bassel Abou-Khalil |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/afbb07a100c54e9ba922ee64de489919 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monotherapy for partial epilepsy: focus on levetiracetam
por: Antonio Gambardella, et al.
Publicado: (2008) -
Changes in background electroencephalography and regional cerebral glucose metabolism in focal epilepsy patients after 1-month administration of levetiracetam
por: Kim SH, et al.
Publicado: (2015) -
Levetiracetam as an alternative therapy for Tourette syndrome
por: MA Martínez-Granero, et al.
Publicado: (2010) -
A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy
por: Zhang LL, et al.
Publicado: (2018) -
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
por: Cormier J, et al.
Publicado: (2013)